Home / Inspections / 949087

FDA Inspection 949087 — Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company

Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company — FEI 2650089

The FDA completed an inspection of Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company on November 17, 2015 in Manati, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 17, 2015
Fiscal Year
2016
Product Type
Devices
Project Area
Compliance: Devices
Location
Manati, PR (United States)

Facility

Other inspections at this facility

  • 1147009 (VAI Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110480 (VAI Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079769 (OAI Wed Feb 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030016 (VAI Mon Sep 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 986929 (NAI Wed May 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources